The reaction of trans -[PdI{C(═NXy)C 6 H 4 NH 2 -2}(CNXy) 2 ] ( 1, Xy = C 6 H 3 Me 2 -2,6) with HO 3 SCF 3 (HOTf) and RC(O)R′ affords 1,2-dihydro-3-xylylquinazolinium-4-yl complexes trans- [PdI{C═N(Xy)C(R)(R′)NHC 6 H 4 -2}(CNXy) 2 ]OTf (R = Me, R′ = Me ( 2a ), Ph ( 2b ), CH 2 C(O)Me ( 2c ), H ( 2d ), R = H, R′ = H ( 2e ), CH═CH 2 ( 2f ), Ph ( 2g ), C 6 H 4 Me-4 (To) ( 2h ), {Fe(C 5 H 4 )(C 5 H 5 )} (Fc) ( 2i )). In the absence of a carbonyl compound, the reaction of 1 with HOTf yields complex SP-4-4- [PdI{ C,N -C(═NHXy)C 6 H 4 NH 2 -2}CNXy]OTf ( 3 ), which reacts with PPh 3 to give SP-4-3- [PdI{C(═NHXy)C 6 H 4 NH 2 -2}(CNXy)(PPh 3 )]OTf ( 4 ). In turn, 4 reacts with RC(O)R′ to give complexes SP-4-3- [PdI{C═N(Xy)C(R)(R′)NHC 6 H 4 -2}(CNXy)(PPh 3 )]OTf (R = R′ = Me ( 2′a ), R = H, R′ = CH(Me)(Ph) ( 2′b ), To ( 2′c )). A possible intermediate in the cyclization process, trans -[PdI{C(═NXy)C 6 H 4 N═CHTo-2}(CNXy) 2 ] ( 6 ), has been prepared by reacting IC 6 H 4 N═CHTo-2, [Pd 2 (dba) 3 ]·dba (“Pd(dba) 2 ”) (dba = dibenzylideneacetone) with N ̂N (to give [PdI(C 6 H 4 N═CHTo-2)(N ̂N)] (N ̂N ̂ = 2,2′-bipyridine (bpy, 5a ), 4,4′-di- tert -butyl-2,2′-bipyridine (tbbp, 5b )) and XyNC. The crystal structures of complexes 2i, 2′a, 3, and 6 have been determined, and the electrochemical behavior of 2i has been studied.
No takes yet. Share an insight, caveat, or question.
Vicente et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: